查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541034

2024-2032 年按细胞激素类型、治疗应用、最终用户和地区分類的细胞激素市场报告

Cytokine Market Report by Cytokine Type, Therapeutic Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球细胞激素市场规模达896亿美元。

细胞激素是指特定细胞释放的一组蛋白质、胜肽或糖蛋白，用于控制免疫系统和血球的生长和活性。由于其高亲和力皮摩尔浓度，它可以调节免疫、发炎和造血功能。它通常被注射到皮下或肌肉或静脉中，以帮助预防或控制化疗副作用并治疗癌症。它还透过发送使异常细胞死亡和正常细胞寿命更长的信号来增强抗癌活性。目前，它在细胞和基因治疗、各种细胞类型的扩增和分化、离体培养和其他治疗方法中已被广泛采用。

细胞激素市场趋势：

冠状病毒病 (COVID-19) 透过飞沫传播，飞沫可诱导促炎细胞因子过量产生，导致急性呼吸窘迫症候群 (ARDS) 加重和组织损伤。由于组织损伤可能导致多重器官衰竭和死亡，因此对细胞因子来管理患者、提高存活率并降低死亡率的解决方案的需求不断增加。除此之外，癌症盛行率的不断上升，加上对微创手术（MIS）的需求不断增加，微创手术可以减少术后疼痛和併发症，并加快恢復时间，从而促进了市场的成长。此外，由于细胞因子可作为健康和疾病的诊断、预后和治疗剂以及生物标记物，因此它们在多种功能中越来越受到关注，包括免疫细胞分化、发炎、血管生成、肿瘤发生、神经生物学和病毒发病机转。除此之外，异位性皮肤炎(AD) 是一种复发性、慢性、发炎性皮肤病，伴随严重搔痒，其病例不断增加，正在推动AD 发病机制中对新细胞因子的需求，并开发改进的治疗标靶。

本报告回答的关键问题：

  • 迄今为止，全球细胞激素市场表现如何，未来几年将如何表现？
  • COVID-19 对全球细胞激素市场有何影响？
  • 主要区域市场有哪些？
  • 根据细胞激素类型的市场划分是怎样的？
  • 基于治疗应用的市场区隔是什么？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球细胞激素市场的结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球细胞激素市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场细分：依细胞激素类型

  • 肿瘤坏死因子
    • 市场趋势
    • 市场预测
  • 白血球介素-II
    • 市场趋势
    • 市场预测
  • 干扰素-IFN
    • 市场趋势
    • 市场预测
  • 表皮生长因子
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依治疗应用分类

  • 癌症
    • 市场趋势
    • 市场预测
  • 气喘和气道炎症
    • 市场趋势
    • 市场预测
  • 关节炎
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 製药和生物技术公司
    • 市场趋势
    • 市场预测
  • 合约研究组织
    • 市场趋势
    • 市场预测
  • 学术及研究机构
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AbbVie Inc.
    • Abcam plc
    • Amgen Inc.
    • Applied Biological Materials Inc. (abm)
    • Bio-Techne Corporation
    • F. Hoffmann-La Roche AG
    • GenScript Biotech Corporation
    • Randox Laboratories Ltd.
    • Thermo Fisher Scientific Inc.
    • UCB SA
Product Code: SR112024A5891

The global cytokine market size reached US$ 89.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 163.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.76% during 2024-2032.

A cytokine refers to a group of proteins, peptides, or glycoproteins released by specific cells to control the growth and activity of the immune system and blood cells. It can regulate immunity, inflammation, and hematopoiesis on account of its high-affinity picomolar concentrations. It is usually injected under the skin or into muscles or veins to help prevent or manage chemotherapy side effects and treat cancer. It also boosts anti-cancer activities by sending signals that make abnormal cells die and normal cells live longer. Presently, it is gaining widespread adoption in cell and gene therapy for the expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches.

Cytokine Market Trends:

The coronavirus disease (COVID-19) is transmitted via droplets that can induce the excessive production of proinflammatory cytokines and lead to acute respiratory distress syndrome (ARDS) aggravation and tissue damage. As tissue damage can result in multi-organ failure and death, there is a rise in the demand for solutions that target cytokines to manage patients, improve survival rates, and reduce mortality. Apart from this, the increasing prevalence of cancer, in confluence with the escalating demand for minimally invasive surgeries (MIS) that provide less post-operative pain and complications and faster recovery time, is contributing to the market growth. Moreover, as cytokines act as diagnostic, prognostic, and therapeutic agents and biomarkers for health and diseases, they are gaining traction in diverse functions, including immune cell differentiation, inflammation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis. Besides this, the rising cases of atopic dermatitis (AD), a recurrent, chronic, and inflammatory skin disease that processes with severe itchiness, is driving the demand for new cytokines in the pathogenesis of AD and developing improved therapeutic targets.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cytokine market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on cytokine type, therapeutic application and end user.

Breakup by Cytokine Type:

Tumor Necrosis Factor-TNF

Interleukins-Il

Interferons-IFN

Epidermal Growth Factor-EGF

Others

Breakup by Therapeutic Application:

Cancer

Asthma and Airway Inflammation

Arthritis

Others

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Academic and Research Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc. and UCB S.A.

Key Questions Answered in This Report:

  • How has the global cytokine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cytokine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cytokine type?
  • What is the breakup of the market based on the therapeutic application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cytokine market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cytokine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cytokine Type

  • 6.1 Tumor Necrosis Factor-TNF
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Interleukins-Il
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Interferons-IFN
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Epidermal Growth Factor-EGF
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Therapeutic Application

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma and Airway Inflammation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Arthritis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Contract Research Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Abcam plc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Amgen Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Applied Biological Materials Inc. (abm)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Bio-Techne Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 GenScript Biotech Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Randox Laboratories Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Thermo Fisher Scientific Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 UCB S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials

List of Figures

  • Figure 1: Global: Cytokine Market: Major Drivers and Challenges
  • Figure 2: Global: Cytokine Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cytokine Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Cytokine Market: Breakup by Cytokine Type (in %), 2023
  • Figure 5: Global: Cytokine Market: Breakup by Therapeutic Application (in %), 2023
  • Figure 6: Global: Cytokine Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Cytokine Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Cytokine (Tumor Necrosis Factor-TNF) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Cytokine (Tumor Necrosis Factor-TNF) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Cytokine (Interleukins-Il) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Cytokine (Interleukins-Il) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Cytokine (Interferons-IFN) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Cytokine (Interferons-IFN) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Cytokine (Epidermal Growth Factor-EGF) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Cytokine (Epidermal Growth Factor-EGF) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Cytokine (Other Cytokine Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Cytokine (Other Cytokine Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Cytokine (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Cytokine (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Cytokine (Asthma and Airway Inflammation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Cytokine (Asthma and Airway Inflammation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Cytokine (Arthritis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Cytokine (Arthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Cytokine (Other Therapeutic Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Cytokine (Other Therapeutic Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Cytokine (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Cytokine (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Cytokine (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Cytokine (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Cytokine (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Cytokine (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Cytokine Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Cytokine Industry: SWOT Analysis
  • Figure 82: Global: Cytokine Industry: Value Chain Analysis
  • Figure 83: Global: Cytokine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cytokine Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cytokine Market Forecast: Breakup by Cytokine Type (in Million US$), 2024-2032
  • Table 3: Global: Cytokine Market Forecast: Breakup by Therapeutic Application (in Million US$), 2024-2032
  • Table 4: Global: Cytokine Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Cytokine Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Cytokine Market: Competitive Structure
  • Table 7: Global: Cytokine Market: Key Players